For further information see below
*The HDPCR™ MDR assay is for research only. Not for use in diagnostic procedures.
The most comprehensive testing in a single test for common gram-negative, gram-positive multi-drug resistance markers and toxigenic Clostridium difficile
Antibiotic resistance is a global concern; expanded antimicrobial stewardship and infection prevention efforts are needed to stop the spread
Get ahead of the problem by using a comprehensive panel for faster colonization testing and characterization of multi-drug resistant infections
HDPCR™ MDR*
Multi-Drug Resistance (MDR) Panel
Extended Spectrum β-Lactamases
CTX-M
Carbapenemases
IMP
KPC
NDM
OXA-48
VIM
Polymyxin Resistance
mcr-2
Vancomycin Resistance (Enterococci)
vanA
Toxigenic C. difficile
tcdB (C. difficile toxin B gene)
*The HDPCR™ MDR assay is for research use only. Not for use in diagnostic procedures
> Increase throughput and decrease time to identification by utilizing an extensive panel that simultaneously screens 9 targets
> Seamless integration & cost effective by utilizing existing qPCR instrumentation and standard workflow
> Streamline data analysis using cloud-based software
> Customize your lab’s needs with selective reporting analysis and scalable throughput
Key Test Specifications
Sample Type
Rectal and Perirectal Swab Specimens
Pure Colonies
Instrument Compatibility
Applied Biosystems™ 7500 Fast / Fast DX
Applied Biosystems™ QuantStudio™ 7
Applied Biosystems™ QuantStudio™ 12K Flex
Applied Biosystems™ ViiA™ 7
Run Time
< 3 Hours
# Sample Wells / # Reportable Targets
1 sample well / 9 reportable targets
Throughput
Scalable: 96-well plate format